Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-128768)

Filing Details

Accession Number:: 0001104659-22-128768
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-20 20:01:10
Reporting Period:: 2022-12-16

Accepted Time:: 2022-12-20 20:01:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571934	Synaptogenix Inc.	SNPX	Pharmaceutical Preparations (2834)	461585656

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686138	L. Daniel Alkon	C/O Synaptogenix, Inc., 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036	President And Cso	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2022-12-16	19,688	$1.17	35,546	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.